Notch signaling is one of the most highly conserved cell-cell communication pathways in multicellular organisms, governing cell fate decisions including proliferation, differentiation, quiescence, and apoptosis across virtually every tissue type. The pathway is named after a notched-wing phenotype first observed in Drosophila nearly a century ago, and it operates through direct physical contact between adjacent cells β a feature that makes it uniquely suited to regulating local tissue architecture, boundary formation, and stem cell niche dynamics. Unlike secreted ligand-receptor systems such as Cytokines or hormones that can act at a distance, Notch requires juxtacrine signaling: the signal-sending cell must be in direct membrane-to-membrane contact with the signal-receiving cell.
In the context of clinical psychoneuroimmunology, Notch signaling is of particular importance because it sits at the intersection of immune cell differentiation, tissue regeneration, and metabolic regulation. Notch determines whether a naive T cell commits to the Th1 or Th2 lineage, whether intestinal stem cells self-renew or differentiate into absorptive versus secretory cell types, whether Satellite cells remain quiescent or activate for muscle repair, and whether macrophages adopt pro-inflammatory or anti-inflammatory phenotypes. These are all processes central to understanding low-grade-inflammation, barrier integrity, and the body's capacity for inflammatory resolution.
Notch signaling also illustrates a core cPNI principle: that cellular fate is not predetermined but context-dependent, shaped by the immediate microenvironment, metabolic state, and inflammatory milieu. When Notch signaling is dysregulated β whether through chronic inflammation, metabolic dysfunction, or aging β the consequences ripple across multiple systems, from impaired wound healing and Sarcopenia to intestinal barrier breakdown and immune dysregulation.
The Notch pathway is remarkably simple in its core architecture yet extraordinarily versatile in its outputs. In mammals, there are four Notch receptors (Notch1, Notch2, Notch3, Notch4), each a single-pass transmembrane protein with large extracellular domains containing epidermal growth factor (EGF)-like repeats that mediate ligand binding. These receptors are activated by five canonical ligands belonging to two families: the Delta-like ligands (DLL1, DLL3, DLL4) and the Jagged ligands (Jagged1, Jagged2), all of which are also transmembrane proteins expressed on adjacent cells. The requirement for both receptor and ligand to be membrane-bound on neighbouring cells is the fundamental constraint that makes Notch a contact-dependent pathway, ensuring that cell fate decisions are made in the context of the immediate tissue niche.
Activation begins when a Notch ligand on the signal-sending cell binds to the extracellular domain of a Notch receptor on the receiving cell. The signal-sending cell then generates a mechanical pulling force through endocytosis of the ligand-receptor complex, which unfolds the negative regulatory region (NRR) of the Notch receptor, exposing a cleavage site. This triggers a cascade of two sequential proteolytic cleavages that liberate the active signaling fragment. The first cleavage (S2) is mediated by ADAM10/ADAM17 metalloprotease (also called TACE), which removes the extracellular domain. The remaining membrane-tethered fragment is then cleaved by the gamma-secretase complex (S3 cleavage) β the same presenilin-containing enzyme complex implicated in Alzheimer's disease and amyloid-beta processing β releasing the Notch intracellular domain (NICD) into the cytoplasm.
The liberated NICD translocates to the nucleus, where it binds to the transcription factor CSL (also known as RBP-Jk in mammals, Su(H) in Drosophila, and Lag-1 in C. elegans). In the absence of NICD, CSL acts as a transcriptional repressor by recruiting co-repressor complexes including histone deacetylases. When NICD binds CSL, it displaces the co-repressor complex and recruits the co-activator Mastermind-like (MAML) protein, forming a ternary activation complex that drives transcription of Notch target genes. The best-characterized targets are the Hes (Hairy and Enhancer of Split) and Hey (Hes-related with YRPW motif) family of basic helix-loop-helix transcription factors. These transcriptional repressors in turn suppress differentiation-promoting genes, thereby maintaining cells in a progenitor or undifferentiated state. NICD has a short half-life and is rapidly ubiquitinated and degraded by the proteasome via PEST domain phosphorylation, ensuring that Notch signaling is tightly pulsatile rather than sustained β a critical feature for its role in oscillatory processes such as somitogenesis and intestinal crypt turnover.
The specificity of Notch signaling outputs depends on which receptor-ligand combination is engaged, the cellular context, the level of Notch activity, and cross-talk with other signaling pathways. Delta-like ligands generally activate Notch in a manner that promotes one cell fate (e.g., Th1 differentiation in T cells), while Jagged ligands often promote the alternative fate (e.g., Th2 differentiation). This ligand-dependent outcome specificity is central to understanding how the same core pathway can produce opposite effects in different immunological contexts.
Notch signaling is the master regulator of satellite cell quiescence. In resting muscle, Notch3 activation maintains Satellite cells in a dormant state through sustained Hes1 expression, which suppresses the myogenic regulatory factor MyoD. When muscle is damaged β through physical activity, injury, or the controlled damage of resistance training β the Notch ligand environment changes: DLL1 is upregulated on damaged myofibers, initially activating Notch in satellite cells to drive their proliferation as transit-amplifying myoblasts. Subsequently, Notch signaling must be downregulated (a process facilitated by the antagonistic Wnt signaling pathway) to allow terminal differentiation and fusion into new myofibers. In aging and Sarcopenia, Notch signaling in satellite cells declines, contributing to impaired regenerative capacity. This is compounded by chronic inflammation: persistent TNF-Ξ± and IL-1Ξ² suppress Notch receptor expression on satellite cells, further impairing the quiescence-activation-differentiation cycle. Interventions that support satellite cell Notch signaling β including Leucine, Omega-3 fatty acids, and resolution of low-grade-inflammation β are therefore central to cPNI strategies for maintaining muscle mass and regenerative capacity across the lifespan.
Notch signaling plays a decisive role in T cell lineage commitment. In the thymus, Notch1 activation by DLL4 on thymic epithelial cells is absolutely required for T cell lineage specification from common lymphoid progenitors β without Notch1 signaling, progenitors default to B cell fate. Beyond this binary T/B decision, Notch signaling influences the differentiation of mature T cells into effector subsets. DLL4-Notch interactions generally promote Th1 and Th17 polarization and the production of IFN-Ξ³ and IL-17, while Jagged1/2-Notch interactions tend to favour Th2 polarization and IL-4 production. This ligand-dependent T cell polarization is regulated by the antigen-presenting cell: Macrophages and dendritic cells alter their expression of Delta-like versus Jagged ligands depending on the pathogen encountered, the cytokine milieu, and their own metabolic state. This mechanism links innate immune activation directly to adaptive immune polarization through cell-contact-dependent Notch signaling.
The intestinal epithelium is the most rapidly renewing tissue in the body, with complete turnover every 3-5 days, and this renewal depends critically on Notch signaling in the crypt stem cell niche. Lgr5+ intestinal stem cells at the crypt base receive Notch signals from adjacent Paneth cells expressing DLL1 and DLL4. Active Notch signaling (through Hes1) directs daughter cells toward the absorptive (enterocyte) lineage, while cells that escape Notch activation (expressing the Notch antagonist Atoh1/Math1) adopt secretory fates β goblet cells, enteroendocrine cells, and Paneth cells themselves. This lateral inhibition mechanism ensures the correct balance between absorptive and secretory cells required for healthy barrier function. When Notch signaling is disrupted β by chronic inflammation, dysbiosis, or metabolic stress β the result is goblet cell hyperplasia (excessive mucus production) or, paradoxically, loss of stem cell maintenance leading to barrier breakdown and increased intestinal permeability. The connection between Notch, intestinal stem cells, and leaky gut is directly relevant to cPNI's emphasis on barrier integrity as a gateway to systemic inflammation.
Notch signaling contributes to Macrophage Polarization, with DLL4-Notch activation generally promoting M1 inflammatory programmes. Notch-activated macrophages show enhanced NF-ΞΊB signaling, increased production of TNF-Ξ±, IL-1Ξ², and IL-6, and metabolic reprogramming toward Aerobic Glycolysis β the Warburg Effect. Conversely, Jagged1-mediated Notch activation has been associated with alternative macrophage activation and anti-inflammatory cytokine production. This means that the tissue context β specifically which Notch ligands are presented by neighbouring cells β directly influences whether macrophages adopt a pro-inflammatory or pro-resolution phenotype.
Notch signaling does not operate in isolation but engages in extensive cross-talk with other pathways central to cPNI. NF-ΞΊB directly activates transcription of Jagged1 and DLL4 ligands, creating a positive feedback loop: inflammation upregulates Notch ligands, which drive further inflammatory Notch signaling, which amplifies NF-ΞΊB activity. This Notch-NF-kB amplification loop is a mechanism by which acute inflammation can become self-sustaining if not resolved by Specialized pro-resolving mediators (SPMs). The Wnt/beta-catenin pathway acts as a functional antagonist of Notch in many contexts: in satellite cells, Wnt activation overrides Notch to permit differentiation; in intestinal crypts, Wnt and Notch cooperate to maintain stemness but have opposing effects on lineage specification. The balance between Notch and Wnt is therefore a key determinant of tissue homeostasis, and its disruption contributes to both Cancer (where Notch can act as either an oncogene or tumour suppressor depending on context) and chronic degenerative disease.